[
  {
    "sentence": "SCCA analysis revealed that in pre-menopausal normal breast tissues, the strongest inter-correlation between NR and coregulators was observed between the five nuclear receptors MR, RARA, RARG, RXRB, LXRβ and a group of 19 coregulators (Fig. 1a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The inter-correlation between these nuclear receptors and coregulators was much stronger in pre-menopausal normal samples than in post-menopausal normal breast (Fig. 1b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Strikingly, the correlation between these NR and coregulators was reduced in pre-menopausal cancers (defined as cancers with age ≤ 50 years; Fig. 1c) or post-menopausal cancers (Fig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In cancer tissues, there was a lower percentage of MR co-expressed genes shared with RARB (104 genes; 21% of MR co-expressed genes identified in breast cancer) (Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Hierarchical clustering of the expression of MR and the three retinoic acid receptors in the TCGA dataset showed that the expression profile of MR more closely resembled that of RARB compared to RARA or RARG (Fig. 2b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Given the data shown in Fig. 1, it is likely that the nature of MR crosstalk with different members of the retinoic acid receptors is dependent on menopausal status.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SCCA analysis revealed that in pre-menopausal normal breast tissues, the strongest inter-correlation between NR and coregulators was observed between the five nuclear receptors MR, RARA, RARG, RXRB, LXRβ and a group of 19 coregulators (Fig. 1a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The inter-correlation between these nuclear receptors and coregulators was much stronger in pre-menopausal normal samples than in post-menopausal normal breast (Fig. 1b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Strikingly, the correlation between these NR and coregulators was reduced in pre-menopausal cancers (defined as cancers with age ≤ 50 years; Fig. 1c) or post-menopausal cancers (Fig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In cancer tissues, there was a lower percentage of MR co-expressed genes shared with RARB (104 genes; 21% of MR co-expressed genes identified in breast cancer) (Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Hierarchical clustering of the expression of MR and the three retinoic acid receptors in the TCGA dataset showed that the expression profile of MR more closely resembled that of RARB compared to RARA or RARG (Fig. 2b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Given the data shown in Fig. 1, it is likely that the nature of MR crosstalk with different members of the retinoic acid receptors is dependent on menopausal status.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the normal breast (Supplementary Fig. 1), gene ontology enrichment analysis revealed that MR and RARB positively correlated genes were enriched with genes involved in cilium assembly, mRNA processing, protein modification (ubiquitination, sumoylation), chromatin modification, cell cycle and DNA damage response (Supplementary Fig. 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In particular, oxidative phosphorylation through the mitochondrial electron transport chain appeared to be enriched in both MR and RARB negatively correlated gene sets (Supplementary Fig. 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, there were a number of functions associated with genes correlated uniquely with either MR or RARB, but not both, in the normal breast, and these are also indicated in Supplementary Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In breast cancer (Supplementary Fig. 2), whereas in the normal breast the pattern of co-expressed genes suggested that MR and RARB shared association with a number of biological processes, many of these connections were lost.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MR positively correlated gene sets were specifically enriched for genes involved in angiogenesis, cell adhesion and response to estradiol (Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "By contrast, RARB positively correlated gene sets were specifically enriched for genes involved in the inflammatory response, apoptosis and protein phosphorylation (Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Gene sets negatively correlated with MR in breast cancer showed strong enrichment for genes involved in cell cycle regulation while RARB correlated gene sets were strongly enriched with genes involved in cellular metabolism (Supplementary Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both MR and RARB were positively correlated with genes involved in transcriptional regulation, cell proliferation and signal transduction (GO terms marked with red boxes in Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Confirming the divergence of functions associated with MR-RARB in the normal breast and breast cancer, there was a poor overlap of correlated genes of MR in normal and cancer (Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "By contrast, Fig. 2c also highlights the strong overlap of MR and RARB correlated genes in normal tissues reflecting the strong overlap in GO terms enriched in MR and RARB co-expressed genes (as shown in Supplementary Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the normal breast (Supplementary Fig. 1), gene ontology enrichment analysis revealed that MR and RARB positively correlated genes were enriched with genes involved in cilium assembly, mRNA processing, protein modification (ubiquitination, sumoylation), chromatin modification, cell cycle and DNA damage response (Supplementary Fig. 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In particular, oxidative phosphorylation through the mitochondrial electron transport chain appeared to be enriched in both MR and RARB negatively correlated gene sets (Supplementary Fig. 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, there were a number of functions associated with genes correlated uniquely with either MR or RARB, but not both, in the normal breast, and these are also indicated in Supplementary Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In breast cancer (Supplementary Fig. 2), whereas in the normal breast the pattern of co-expressed genes suggested that MR and RARB shared association with a number of biological processes, many of these connections were lost.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MR positively correlated gene sets were specifically enriched for genes involved in angiogenesis, cell adhesion and response to estradiol (Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "By contrast, RARB positively correlated gene sets were specifically enriched for genes involved in the inflammatory response, apoptosis and protein phosphorylation (Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Gene sets negatively correlated with MR in breast cancer showed strong enrichment for genes involved in cell cycle regulation while RARB correlated gene sets were strongly enriched with genes involved in cellular metabolism (Supplementary Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both MR and RARB were positively correlated with genes involved in transcriptional regulation, cell proliferation and signal transduction (GO terms marked with red boxes in Supplementary Fig. 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Confirming the divergence of functions associated with MR-RARB in the normal breast and breast cancer, there was a poor overlap of correlated genes of MR in normal and cancer (Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "By contrast, Fig. 2c also highlights the strong overlap of MR and RARB correlated genes in normal tissues reflecting the strong overlap in GO terms enriched in MR and RARB co-expressed genes (as shown in Supplementary Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MR is robustly expressed both at the mRNA and protein expression level when induced with doxycycline (Fig. 3a and b, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3c shows the number of genes differentially expressed on ALDO, RA or ALDO+RA treatment in MR-inducible breast cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3d shows the overlap of the differentially expressed genes for the three treatment conditions.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3e shows a clustered heatmap of the expression of all genes differentially expressed in any of the three treatment conditions.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO- and RA-regulated genes were largely non-overlapping, except for the small clusters 6 and 7 (Fig. 3e).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO+RA treatment resulted in the acquired differential expression of a substantial number of genes that were not regulated when cells were treated with ALDO alone or RA alone (Fig. 3e, cluster 1).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO+RA treatment also resulted in loss of differential expression of genes regulated by either ALDO or RA alone (Fig. 3e, clusters 2 and 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Grey indicates no significant GO term was identifiedTo better understand the biological processes influenced by ALDO and RA signalling, gene ontology enrichment analysis was performed on each of the gene clusters identified in Fig. 3e and summarized in Fig. 3f.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Genes associated with RNA transcription and post-transcriptional processing (GO terms in black) were largely downregulated by RA and ALDO+RA (Fig. 3e, f; clusters 1a and 4a), whereas ALDO and ALDO+RA appeared to regulate gene expression associated with growth inhibition (green GO terms, Fig. 3e, f; clusters 5a and 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Co-treatment of ALDO+RA upregulated a set of genes involved in the response to endoplasmic reticulum stress (GO terms in pink, Fig. 3e, f; clusters 1b and 5c), whereas these genes did not show significant expression change with ALDO or RA single treatments.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Genes involved in oxidative phosphorylation (GO terms in blue text) were downregulated in both RA single treatment and ALDO+RA co-treatment (Fig. 3e, f, clusters 4a and 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, many genes involved in glycolysis were upregulated in ALDO, RA and ALDO+RA treatments (Fig. 3e, side panel).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Key pro-glycolysis genes were increased by MR-RAR activation (Fig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "When these effects were overlaid onto a schematic diagram (Fig. 4b) of the key cellular metabolic pathways affecting glycolysis and oxidative phosphorylation in cancer cells, it was noted that in addition to promoting glycolysis and downregulating many genes involved in oxidative phosphorylation, ALDO+RA treatment also upregulated PDK4, which is known to inhibit the pyruvate dehydrogenase (PDH) complex, an enzyme that catalyses the oxidative decarboxylation of pyruvate to acetyl-CoA, the input into the Krebs cycle.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nEffect of ALDO+RA treatment on cellular metabolism. a The fold change in expression on ALDO+RA treatment in MR-inducible MCF-7 cells for differentially expressed metabolic genes. b Schematic diagram of the glycolysis pathways (adapted from [31]), highlighting in red the key genes that show differential expression in the ALDO+RA treatment. c Heatmap of the expression level of key genes involved in glucose metabolism in normal samples, cancer samples, cancer samples expressing high level of both MR and RARB and cancer samples expressing low level of both MR and RARB from the TCGA breast cancer RNA-Seq datasetTo test the prediction that MR-RAR activation was consistent with increased glycolysis in cancer samples, the genes in Fig. 4a were measured in the TCGA dataset (Fig. 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In support of the findings in the cell line, breast cancers expressing high levels of MR and RARB express higher levels of key pro-glycolysis genes compared with cancers with low MR/RARB expression (Fig. 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "PDK4 expression is however higher in the normal breast when compared to breast cancer tissues as shown in Fig. 4c.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "It can be observed in Fig. 4c that in addition to PDK4, the expression profiles of other key pro-glycolysis genes including BNIP3L and BFKFB3 are higher in the normal breast compared to breast cancer tissues.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MR is robustly expressed both at the mRNA and protein expression level when induced with doxycycline (Fig. 3a and b, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3c shows the number of genes differentially expressed on ALDO, RA or ALDO+RA treatment in MR-inducible breast cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3d shows the overlap of the differentially expressed genes for the three treatment conditions.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3e shows a clustered heatmap of the expression of all genes differentially expressed in any of the three treatment conditions.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO- and RA-regulated genes were largely non-overlapping, except for the small clusters 6 and 7 (Fig. 3e).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO+RA treatment resulted in the acquired differential expression of a substantial number of genes that were not regulated when cells were treated with ALDO alone or RA alone (Fig. 3e, cluster 1).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ALDO+RA treatment also resulted in loss of differential expression of genes regulated by either ALDO or RA alone (Fig. 3e, clusters 2 and 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "To better understand the biological processes influenced by ALDO and RA signalling, gene ontology enrichment analysis was performed on each of the gene clusters identified in Fig. 3e and summarized in Fig. 3f.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Genes associated with RNA transcription and post-transcriptional processing (GO terms in black) were largely downregulated by RA and ALDO+RA (Fig. 3e, f; clusters 1a and 4a), whereas ALDO and ALDO+RA appeared to regulate gene expression associated with growth inhibition (green GO terms, Fig. 3e, f; clusters 5a and 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Co-treatment of ALDO+RA upregulated a set of genes involved in the response to endoplasmic reticulum stress (GO terms in pink, Fig. 3e, f; clusters 1b and 5c), whereas these genes did not show significant expression change with ALDO or RA single treatments.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Genes involved in oxidative phosphorylation (GO terms in blue text) were downregulated in both RA single treatment and ALDO+RA co-treatment (Fig. 3e, f, clusters 4a and 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, many genes involved in glycolysis were upregulated in ALDO, RA and ALDO+RA treatments (Fig. 3e, side panel).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Key pro-glycolysis genes were increased by MR-RAR activation (Fig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "When these effects were overlaid onto a schematic diagram (Fig. 4b) of the key cellular metabolic pathways affecting glycolysis and oxidative phosphorylation in cancer cells, it was noted that in addition to promoting glycolysis and downregulating many genes involved in oxidative phosphorylation, ALDO+RA treatment also upregulated PDK4, which is known to inhibit the pyruvate dehydrogenase (PDH) complex, an enzyme that catalyses the oxidative decarboxylation of pyruvate to acetyl-CoA, the input into the Krebs cycle.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To test the prediction that MR-RAR activation was consistent with increased glycolysis in cancer samples, the genes in Fig. 4a were measured in the TCGA dataset (Fig. 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In support of the findings in the cell line, breast cancers expressing high levels of MR and RARB express higher levels of key pro-glycolysis genes compared with cancers with low MR/RARB expression (Fig. 4c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "PDK4 expression is however higher in the normal breast when compared to breast cancer tissues as shown in Fig. 4c.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "It can be observed in Fig. 4c that in addition to PDK4, the expression profiles of other key pro-glycolysis genes including BNIP3L and BFKFB3 are higher in the normal breast compared to breast cancer tissues.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "As an indicator of cell proliferation, we measured the meta-PCNA genes (Fig. 5b shows a clustered heatmap of the expression of meta-PCNA genes) as well as calculated the meta-PCNA index (Fig. 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5a shows the median expression of the meta-PCNA genes for each treatment condition with associated P values based on the paired Wilcoxon signed-rank test of the expression of the meta-PCNA genes.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Reflecting the known proliferative effect of E2 in breast cancer cells and confirming the activation of proliferative pathways in this cell line model, the PCNA index of E2-treated cells was highest (Fig. 5a, where DOX treatment alone, which is used to induce MR, is equivalent to vehicle treatment).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This was confirmed by examination of the individual expression of the meta-PCNA genes, showing E2 activation of proliferative genes (Fig. 5b, yellow cluster).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Neither MR nor RARB activation increased the PCNA index, and in fact, ALDO-treated cells had a lower PCNA index compared to cells treated with DOX alone, and DOX+ALDO+RA-treated cells showed a further decrease in the PCNA index (Fig. 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Based on the overall distribution of the expression estimates of all transcripts represented by probes on the Illumina human whole genome array used for this dataset (Supplementary Fig. 3A), we defined any transcript with expression level > 6 to be expressed.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "RARB was detected above the threshold in 24% of breast cancers and MR was present in 71% of cases (Supplementary Fig. 3B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Breast cancer cases from the METABRIC dataset were classified into four sample subgroups based on the expression of MR and RARB (Fig. 6a).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Kaplan-Meier analysis revealed that breast cancers that were characterized by high expression of both MR and RARB represented a subgroup with significantly better survival (Fig. 6b).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "High expression of only one of the two receptors or low or absent expression of both receptors was not associated with equivalently good outcome as their combined high expression (Fig. 6b).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The characteristics of the reverse Warburg effect are summarized in Fig. 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The characteristics of the reverse Warburg effect are summarized in Fig. 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  }
]